Emmaus Life Sciences Inc (EMMA)
0.10
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Emmaus Life Sciences Shareholders Equity (Quarterly): -36.33M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -36.33M |
June 30, 2023 | -35.03M |
March 31, 2023 | -35.95M |
December 31, 2022 | -34.09M |
September 30, 2022 | -37.59M |
June 30, 2022 | -34.64M |
March 31, 2022 | -22.30M |
December 31, 2021 | -21.45M |
September 30, 2021 | -15.10M |
June 30, 2021 | -9.375M |
March 31, 2021 | -12.68M |
December 31, 2020 | -5.158M |
September 30, 2020 | -6.365M |
June 30, 2020 | -14.02M |
March 31, 2020 | -4.732M |
December 31, 2019 | -11.05M |
September 30, 2019 | -17.52M |
June 30, 2019 | 3.800M |
March 31, 2019 | 2.024M |
December 31, 2018 | 2.166M |
September 30, 2018 | 4.021M |
June 30, 2018 | 3.115M |
March 31, 2018 | 1.837M |
December 31, 2017 | 2.130M |
September 30, 2017 | 4.547M |
Date | Value |
---|---|
June 30, 2017 | -0.9531M |
March 31, 2017 | 0.5268M |
December 31, 2016 | 0.7688M |
September 30, 2016 | -1.064M |
June 30, 2016 | -7.470M |
March 31, 2016 | -6.613M |
December 31, 2015 | -6.653M |
September 30, 2015 | -4.836M |
June 30, 2015 | -3.643M |
March 31, 2015 | -3.149M |
December 31, 2014 | -2.552M |
September 30, 2014 | -1.762M |
June 30, 2014 | -1.354M |
March 31, 2014 | -0.5076M |
December 31, 2013 | -0.8333M |
September 30, 2013 | -2.16M |
June 30, 2013 | -11.11M |
March 31, 2013 | -11.57M |
December 31, 2012 | -13.68M |
September 30, 2012 | -13.07M |
June 30, 2012 | -17.92M |
March 31, 2012 | -21.88M |
December 31, 2011 | -13.82M |
September 30, 2011 | -11.42M |
June 30, 2011 | -9.105M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-37.59M
Minimum
Sep 2022
3.800M
Maximum
Jun 2019
-19.42M
Average
-16.31M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 75.18M |
Protalix BioTherapeutics Inc | 33.57M |
Electromed Inc | 40.34M |
Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 47.45M |
Total Liabilities (Quarterly) | 83.78M |
Debt to Equity Ratio | -0.8928 |
Current Ratio | 0.152 |
Net Debt Paydown Yield | -1.75% |